Cochrane Abstracts
Haloperidol discontinuation for people with schizophrenia
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Haloperidol Discontinuation for People With Schizophrenia." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/433050/all/Haloperidol_discontinuation_for_people_with_schizophrenia. Accessed 05 October 2024.
Haloperidol discontinuation for people with schizophrenia. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/433050/all/Haloperidol_discontinuation_for_people_with_schizophrenia. Accessed October 5, 2024.
Haloperidol discontinuation for people with schizophrenia. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/433050/all/Haloperidol_discontinuation_for_people_with_schizophrenia
Haloperidol Discontinuation for People With Schizophrenia [Internet]. In: Cochrane Abstracts. [cited 2024 October 05]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/433050/all/Haloperidol_discontinuation_for_people_with_schizophrenia.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Haloperidol discontinuation for people with schizophrenia
ID - 433050
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/433050/all/Haloperidol_discontinuation_for_people_with_schizophrenia
DB - Evidence Central
DP - Unbound Medicine
ER -
